Walleye Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Walleye Trading’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,800	Closed	-$32K	–	4943
2020 Q2	$32K	Sell	1,800 -200	-10%	-$2.78K	﹤0.01%	3910
2020 Q1	$14K	Sell	2,000 -53,400	-96%	-$666K	﹤0.01%	3677
2019 Q4	$1.32M	Buy	55,400 +46,300	+509%	+$1.28M	0.01%	1559
2019 Q3	$244K	Buy	9,100 +2,800	+44%	+$78.6K	﹤0.01%	2786
2019 Q2	$171K	Sell	6,300 -12,200	-66%	-$383K	﹤0.01%	3052
2019 Q1	$642K	Sell	18,500 -5,000	-21%	-$144K	0.01%	2049
2018 Q4	$459K	Sell	23,500 -3,300	-12%	-$67.9K	﹤0.01%	2559
2018 Q3	$714K	Buy	26,800 +22,300	+496%	+$728K	﹤0.01%	2479
2018 Q2	$170K	Buy	+4,500	New	+$172K	﹤0.01%	3739

Walleye Trading's PTLA Position: Q3 2020 in Review

Walleye Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 18,001 shares — an estimated $324K sold.

Walleye Trading first reported a position in PTLA in Q2 2015 and held it in 12 quarters. The position peaked at $574K in Q4 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Walleye Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Walleye Trading sold 18,001 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $324K.
Walleye Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
Walleye Trading's Portola Pharmaceuticals, Inc. position peaked at $574K in Q4 2018.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.